In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

The change is expected to save at least 90 days in the drug development life cycle — a major boost for research timelines and ...

HANGZHOU CITY, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of the pharmaceutical and ...

To reduce regulatory burden and promote ease of doing business, the Centre has amended the New Drugs and Clinical Trials ...

To reduce regulatory burden and promote ease of doing business, the Centre has amended the New Drugs and Clinical Trials ...

Copenhagen, DK and Boston, MA, U.S. November 05, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078,) a biotechnology company focused on the discovery, development and commercialization of ...

AI is remaking health care – and that includes gene-based precision medicine, among other types of rapid advances in treatment. The growing field of GenAI, or genetic AI, uses advanced algorithms ...

Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, ...

Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its ...

NEW YORK and VIENNA, Austria, Jan. 16, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary ...

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland) -- The transaction is subject to customary closing ...

JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (RDW), a global leader in space and defense technology solutions, today announced that it has formed a new entity, SpaceMD, which will focus ...